Donor-Derived CD19 CAR-T Cells Deliver Lasting Remissions in Leukemia Patients After Transplant Failure
A Chinese clinical study reports that donor-derived anti-CD19 CAR-T cells achieved complete remissions in 13 of 14 patients whose B-cell ...
A Chinese clinical study reports that donor-derived anti-CD19 CAR-T cells achieved complete remissions in 13 of 14 patients whose B-cell ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine